Bill Gerard joins Formula Plastics as President

Executive Change
Formula Plastics, an Arterex company, has announced that Bill Gerard has joined the company as its president effective immediately. Bill brings 26 years of experience in medical device contract manufacturing, most recently as President of Carlisle’s Contract Manufacturing group (formerly Providien Medical). Prior to Carlisle and Providien, Bill worked at The Tech Group, a medical device CMO with locations across the United States, Latin America, Europe and Asia.  During his tenure at The Tech Group, Bill held positions of increasing responsibility, including managing director of Tech Group Latin America, vice president of engineering, and finally as vice president of operations, helping lead the organisation through their acquisition by West Pharmaceutical. “Bill is a proven leader and brings exceptional experience, specific medical device manufacturing knowledge and additional operational depth to Formula”, commented Charles Stroupe, executive chairman of Arterex, and added, “as we develop the Arterex business in the US and internationally, it is critical to have proven leaders with deep industry experience to lead our companies and execute the Arterex global strategy for the benefit of all our customers, staff and stakeholders.” “I’m excited to be joining Formula Plastics and the Arterex team, and I am looking forward to building a significant, successful business with the Formula platform.  It’s exciting to be joining with business partners who understand this industry and its keys to success," stated Bill Gerard, Formula’s new president.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.